Company profile for Neovacs

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Neovacs, founded in 1993 as a spin-off of Paris Sorbonne University, focuses on developing Kinoid-based immunotherapies and investing in innovative biotech and medtech ventures. Its R&D centers around the patented Kinoid platform, targeting lupus and allergies, including asthma. Having completed a Phase IIb trial for lupus, the company is now optimizing manufacturing for its IL-4/IL-13 Kinoid candidate. Alongside R&D, Neovacs ...
Neovacs, founded in 1993 as a spin-off of Paris Sorbonne University, focuses on developing Kinoid-based immunotherapies and investing in innovative biotech and medtech ventures. Its R&D centers around the patented Kinoid platform, targeting lupus and allergies, including asthma. Having completed a Phase IIb trial for lupus, the company is now optimizing manufacturing for its IL-4/IL-13 Kinoid candidate. Alongside R&D, Neovacs leverages its scientific and financial expertise to invest in promising drug and medical device projects.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
France
Address
Address
35 Impasse Reille, 75014 Paris
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty